Autologous dendritic cell vaccine transduced with adenoviral NS3 vector
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous dendritic cell vaccine transduced with adenoviral NS3 vector, covering 2017-10-24 to 2017-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C [Phase 1, Phase 2]